Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic Rhinitis by Lina Mattson, Antonio Lentini, Danuta R. Gawel, Tejaswi V. S. Badam, Mikael Benson, Torbjorn Ledin, Colm E. Nestor, Mika Gustafsson, Jordi Serra-Musach, Janne Bjorkander, Zou Xiang, Huan Zhang

“…Recent studies report type I interferons shifting the balance between type I T helper cell (Th1) and type II T helper cells (Th2) towards Th2 dominance by inhibiting the differentiation of naive T cells into Th1 cells. …”
Get full text

Irreversible Anterior Ischemic Optic Neuropathy Complicating Interferon Alpha and Ribaverin Therapy by Hassan Seddik, Mouna Tamzaourte, Fadoua Rouibaa, Maha Fadlouallah, Ahmed Benkirane

“…Ophthalmologic complications with interferon therapy are rare and usually reversible. …”
Get full text

A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin by Nisha Mistry, Jonathan Shapero, Richard I Crawford

“…The present article reviews different presentations of drug-induced cutaneous eruptions, with a focus on eruptions reported secondary to the use of interferon and ribavirin. Presentations include injection site reactions, psoriasis, eczematous drug reactions, alopecia, sarcoidosis, lupus, fixed drug eruptions, pigmentary changes and lichenoid eruptions. …”
Get full text

Matrine relieved DHAV-1-induced hepatocyte excessive interferon and pyroptosis by activating mitophagy by Weiran Wang, Xiang Fu, Bolin Gu, Mengxin Hu, Jiaguo Liu

“…Additionally‌, by incorporating the autophagy inhibitor chloroquine, we observed that the effects of matrine on the regulation of excessive interferon (IFN) production, pyroptosis, mitochondrial damage, and oxidative stress were reversed. …”
Get full text

Application and Interpretation of an Interferon-Gamma Release Assay: Results of an Audit in a Canadian Centre by Sopharat Vat, Marc Ghannoum, Pierre Laflamme, Mario Dugas, Manon Labrecque, Valéry Lavergne

“…BACKGROUND: Interferon-gamma release assays (IGRAs) are newly approved for diagnosing latent tuberculosis infection (LTBI). …”
Get full text

Association between Interferon-Inducible Protein 6 () Polymorphisms and Hepatitis B Virus Clearance by Geun-Hee Park, Kyoung-Yeon Kim, Sung Won Cho, Jae Youn Cheong, Gyeong Im Yu, Dong Hoon Shin, Kyu Bum Kwack

“…However, these cells are killed through HBV-induced apoptosis during the antigen-presenting period in HBV-induced chronic liver disease (CLD) patients. Interferon-inducible protein 6 (IFI6) delays type I interferon-induced apoptosis in cells. …”
Get full text

Divergent Effects of <i>Circoviridae</i> Capsid Proteins on Type I Interferon Signaling by Anon H. Kosaka, Chen-Yu Huang, Zih-Ying Lu, Hua-Zhen Hsing, Amonrat Choonnasard, Rissar Siringo Ringo, Kuo Pin Chuang, Akatsuki Saito

Subjects: Get full text

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis by Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales

Subjects: Get full text

Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis by Éric Toussirot, Matthieu Béreau, Marie Bossert, Imad Malkoun, Anne Lohse

“…Interferon beta (IFN-β) is the first line therapy of relapsing-remitting multiple sclerosis. …”
Get full text

Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes by S.J.W. Kang, G.W. Eather, F. Qureshi, J.R. Scott

“…BACKGROUND: An ‘indeterminate’ interferon-gamma release assay (IGRA) result used in the diagnosis of latent TB infection (LTBI) is most commonly due to an inadequate control (or ‘mitogen’) response, which may reflect underlying T-cell dysfunction. …”
Get full text

Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis by Xidong He, Yuanxue Gao, Qi Liu, Zhifang Zhao, Wanhang Deng, Hong Yang

“…To investigate the diagnostic value of interferon-gamma release assays combined with multiple indicators for tuberculous peritonitis. …”
Get full text

An artificial transcription factor that activates potent interferon-γ expression in human Jurkat T Cells by Ashley King, Davis Noblitt, Olivia Sherron, Olivia Sherron, Clara Kjerfve, Lydia Pless, Nicholas L. Truex

Subjects: Get full text

Interferon gamma‐mediated prevention of tumor progression in a mouse model of multiple myeloma by Zoltán Kellermayer, Sabrin Tahri, Madelon M. E. deJong, Natalie Papazian, Cathelijne Fokkema, Elodie C. G. Stoetman, Remco Hoogenboezem, Gregory vanBeek, Mathijs A. Sanders, Louis Boon, Chelsea Den Hollander, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo

“…Single‐cell RNA‐sequencing of immune cells and bulk RNA sequencing of immune and mesenchymal stromal cells implicated the activation of interferon responses as a central immune pathway during stable disease. …”
Get full text

Diagnostic value of interferon-γ release assay in patients with COPD complicated with pulmonary tuberculosis by Yanxiao Rong, Haibin Wang, Yuanyuan Su, Qian Wang, Xuepei Sun, Wei Wang

Subjects: Get full text

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C by R. Rodríguez-Lojo, M. Almagro, J. M. Barja, F. Piñeyro, L. Pérez-Varela, J. Del Pozo, M. T. Yebra-Pimentel, E. Fonseca

“…Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. …”
Get full text

The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C by F. Bellanti, G. Vendemiale, E. Altomare, G. Serviddio

“…Very recently, three landmark genome-wide association studies identified single nucleotide polymorphisms near the interleukin 28B (IL28B) region which were more frequent in responders to treatment. IL28B encodes interferon (IFN)λ3, a type III IFN involved in host antiviral immunity. …”
Get full text

HDAC6 Facilitates PRV and VSV Infection by Inhibiting Type I Interferon Production by Hu Zheng, Xiaohui Yang, Haiwen Zhong, Changxu Song, Zhenfang Wu, Huaqiang Yang

Get full text

Ischemic Colitis During Pegylated Interferon-Alpha and Ribavirin Therapy for Chronic Hepatitis C by Yvette Leung, Stefan J Urbanski, Lynn Schindel, Robert P Myers

“…Rare cases of ischemic colitis associated with interferon-alpha (IFN-α) treatment for chronic hepatitis C (HCV) infection and metastatic cancer have been reported. …”
Get full text

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C by M. V. Mayevskaya, O. O. Znoyko, E. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya

Get full text

Differential Impairment of Interferon-γ Responses in Two Cases of Pulmonary Nontuberculous Mycobacterial Disease by William Rae, Yifang Gao, Efrem Eren, Rainer Döffinger, Ben Marshall, Anthony P. Williams

Get full text